Q-Linea
1,192
SEK
-1 %
QLINEA
NASDAQ Stockholm
Medical Equipment & Services
Health Care
1 investor følger denne virksomhed
-1%
-51,74%
-64,68%
-53,16%
-67,78%
-57,43%
-98,89%
-97,87%
-98,23%
www.qlinea.com/sv
Q-Linea is active in medical technology. The company specializes in the research and development of instruments and consumables. The products are mainly used in the treatment of infectious diseases and blood poisoning and include diagnostic and analysis tools, as well as other related basic sample handlings. The technology is based on the so-called ID and AST technology. The company was founded in 2008 and is headquartered in Uppsala.
Omsætning
4,44 mio.
EBIT %
-5.193,47 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
QLINEA
Daglig lav / høj pris
1,15 / 1,244
SEK
Markedsværdi
139,66 mio. SEK
Aktieomsætning
197,24 t SEK
Volumen
165 t
Seneste videoer
Finanskalender
Ekstraordinær generalforsamling
06.12.2024
Årsrapport
13.02.2025
Delårsrapport
03.05.2025
Generalforsamling
22.05.2025
Delårsrapport
10.07.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Nexttobe AB | 53,5 % | 53,5 % |
Fjärde AP-fonden | 7,4 % | 7,4 % |
Investment AB Öresund | 6,8 % | 6,8 % |
Nordnet Pensionsförsäkring | 4,7 % | 4,7 % |
Avanza Pension | 1,6 % | 1,6 % |
Ulf Landegren | 1,5 % | 1,5 % |
Cancerfonden - Riksföreningen Mot Cancer | 1,1 % | 1,1 % |
Aktie-Ansvar Fonder | 1,0 % | 1,0 % |
Mats Nilsson | 0,9 % | 0,9 % |
SEB-Stiftelsen | 0,6 % | 0,6 % |
ViserAlle indholdstyper
Q-Linea, Audiocast with teleconference, Q3'24
Interim report 1 January - 30 September 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools